Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | STAT3 | P40763 | 15/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Barlerin SCHEMBL29425807 | 1.00 | POLB (0.56) | POLBCTDSP1STAT3MAPTMEN1 | |
| Shanzhiside Methyl Ester SCHEMBL12207355 | 0.87 | POLB (0.62) | POLBCTDSP1STAT3MAPTMEN1 | |
| Shanzhiside Methyl Ester SCHEMBL28007134 | 0.87 | POLB (0.62) | POLBCTDSP1STAT3MAPTMEN1 | |
| Shanzhiside Methyl Ester SCHEMBL29965826 | 0.87 | POLB (0.62) | POLBCTDSP1STAT3MAPTMEN1 | |
| SCHEMBL29425753 | 0.80 | ELANE (0.58) | POLBCTDSP1STAT3MAPTMEN1 | |
| SCHEMBL29425883 | 0.80 | ELANE (0.58) | POLBCTDSP1STAT3MAPTMEN1 | |
| Lamalbid SCHEMBL9056954 | 0.80 | POLB (0.66) | POLBCTDSP1STAT3MAPTMEN1 | |
| Phlorigidoside C SCHEMBL29425891 | 0.79 | POLB (0.61) | POLBCTDSP1STAT3MAPTMEN1 | |
| SCHEMBL3202619 | 0.78 | HSP90AA1 (0.50) | POLBCTDSP1STAT3MAPTMEN1 | |
| SCHEMBL29425776 | 0.78 | POLB (0.52) | POLBCTDSP1STAT3MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120078793-A | Application of iridoid compound in parkinsonism neuroprotection drugs | 桂林医学院附属医院 | 2025-06-03 | — | — | CN | claimed |
| WO-2024190919-A1 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, COMPOUND, AND ACID DIFFUSION CONTROL AGENT | 東京応化工業株式会社 | 2024-09-19 | — | — | WO | claimed |
| CN-118272268-A | Heterotrophic nitrification-aerobic denitrification paracymenia and application thereof | 闽江学院 | 2024-07-02 | — | — | CN | claimed |
| CN-115657324-A | Light combining mechanism and optical lens | 广东科视光学技术股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-1496920-B1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | COUNCIL SCIENT IND RES (IN) | 2010-03-03 | — | — | EP | claimed |
| EP-1496920-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) (IN) | 2005-01-19 | — | — | EP | claimed |
| US-6664236-B2 | Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-12-16 | — | — | US | claimed |
| WO-2003080087-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-02 | — | — | WO | claimed |
| US-20030181397-A1 | SYNERGISTIC COMPOSITION OF BIOACTIVE FRACTION ISOLATED BARLERIA PRIONITIS LINN AND A METHOD OF TREATMENT FOR HEPATOTOXICITY, IMMUNO-DEFICIENCY AND FATIGUE AND A PROCESS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-09-25 | — | — | US | claimed |
| CN-122075799-A | Hydrogel for cartilage repair and preparation method thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122063760-A | Ultra-wide-angle small-sized automatic focusing lens and image pickup device | 深圳市唯卓仕科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12580569-B2 | Multi-bit level shifter | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-03-17 | — | — | US | disclosed |
| CN-121606591-A | Breast cancer cell inhibitor containing 8-O-acetyl shanzhiside methyl ester and application thereof | 桂林医科大学第一附属医院 | 2026-03-06 | — | — | CN | disclosed |
| US-12562720-B2 | Method of forming semiconductor device including daisy-chained delay cells | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-02-24 | — | — | US | disclosed |
| CN-1627954-A | Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn | COUNCIL SCIENT IND RES (IN) | 2005-06-15 | — | — | CN | disclosed |
| EP-1496920-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) (IN) | 2005-01-19 | — | — | EP | disclosed |
| US-6664236-B2 | Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-12-16 | — | — | US | disclosed |
| WO-2003080087-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-02 | — | — | WO | disclosed |
| US-20030181397-A1 | SYNERGISTIC COMPOSITION OF BIOACTIVE FRACTION ISOLATED BARLERIA PRIONITIS LINN AND A METHOD OF TREATMENT FOR HEPATOTOXICITY, IMMUNO-DEFICIENCY AND FATIGUE AND A PROCESS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-09-25 | — | — | US | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12580569-B2 | Multi-bit level shifter | HCN4, SOS2, CACNB2 | POLB 4698/4885CTDSP1 4188/4885STAT3 252/4885 |
| US-12562720-B2 | Method of forming semiconductor device including daisy-chained delay cells | DSP, DSC1, DSG1 | POLB 2197/4885CTDSP1 231/4885STAT3 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.